These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30715376)

  • 21. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
    J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
    Neu KE; Henry Dunand CJ; Wilson PC
    Curr Opin Immunol; 2016 Oct; 42():48-55. PubMed ID: 27268395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.
    De Groot AS; McClaine E; Moise L; Martin W
    Hum Vaccin; 2010 Feb; 6(2):161-63. PubMed ID: 20431339
    [No Abstract]   [Full Text] [Related]  

  • 26. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.
    Sant AJ; DiPiazza AT; Nayak JL; Rattan A; Richards KA
    Immunol Rev; 2018 Jul; 284(1):91-105. PubMed ID: 29944766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
    Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
    J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stringing Together a Universal Influenza Antibody.
    Cerulli RA; Kritzer JA
    Biochemistry; 2019 Apr; 58(15):1943-1944. PubMed ID: 30946571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric influenza vaccination: understanding the T-cell response.
    Bodewes R; Fraaij PL; Osterhaus AD; Rimmelzwaan GF
    Expert Rev Vaccines; 2012 Aug; 11(8):963-71. PubMed ID: 23002977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    Alam S; Chan C; Qiu X; Shannon I; White CL; Sant AJ; Nayak JL
    PLoS One; 2017; 12(5):e0176407. PubMed ID: 28493882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus.
    Nelson SA; Sant AJ
    Front Immunol; 2019; 10():932. PubMed ID: 31134060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
    Moise L; M Biron B; Boyle CM; Kurt Yilmaz N; Jang H; Schiffer C; M Ross T; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2018; 14(9):2203-2207. PubMed ID: 30015562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.
    Nienen M; Stervbo U; Mölder F; Kaliszczyk S; Kuchenbecker L; Gayova L; Schweiger B; Jürchott K; Hecht J; Neumann AU; Rahmann S; Westhoff T; Reinke P; Thiel A; Babel N
    Front Immunol; 2019; 10():593. PubMed ID: 31019503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
    Ramírez-Salinas GL; García-Machorro J; Rojas-Hernández S; Campos-Rodríguez R; de Oca AC; Gomez MM; Luciano R; Zimic M; Correa-Basurto J
    Arch Virol; 2020 Apr; 165(4):891-911. PubMed ID: 32060794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human influenza viruses and CD8(+) T cell responses.
    Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
    Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.
    Patil V; Renu S; Feliciano-Ruiz N; Han Y; Ramesh A; Schrock J; Dhakal S; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2020; 11():596964. PubMed ID: 33391267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines.
    Ohshima N; Iba Y; Kubota-Koketsu R; Yamasaki A; Majima K; Kurosawa G; Hirano D; Yoshida S; Sugiura M; Asano Y; Okuno Y; Kurosawa Y
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.